Skip to main content

Table 1 Characteristics of studies reporting cancer-specific survival for endometrial cancer patients with diabetes compared to without

From: Survival outcomes in endometrial cancer patients according to diabetes: a systematic review and meta-analysis

Author,

year and

location

Study design

Study cohort source/database

Endometrial cancer study population

Recruitment period

Study size

Diabetes ascertainment

No. of EC-specific deaths

Risk estimate reported

Outcome ascertainment

Follow-up (mean/ median)

NOS score

Bjornsdottir[56]

2020

Sweden

Population-based

Swedish Cancer Registry

NR

1998–2012

NR

The Swedish National Diabetes Register

NR

HR

The Total Population Register and Swedish Cause of Death Registry

6.6 years (median)

7

Brandt[51]

2019

U.S

Single institution-based

Memorial Sloan Kettering Cancer Centre

Stage I

2006–2016

1458

Medical records

NR

HR

NR

2.4 years (median)

6

Donkers [57]

2021

U.K

Single institution-based

Royal Cornwall Hospital Trust

Truro, Cornwall

High grade EC stages I-IV

2006–2017

176

Medical records

70

HR

Medical records

NR

8

Felix[34]

2015

U.S

Multi institution-based

NRG Oncology/Gynecologic Oncology Group 210 molecular staging trial

Stages I-IV

2003–2011

4109

Self-reported

582

HR

Medical records and cancer registry

5 years (median)

6

Folsom[18]

2004

U.S

Population-based

Iowa women’s health study and SEER cancer registry

Stages I-IV

1986–2000

415

Self-reported

39

RR

Registry, questionnaires and NDI

6.4 years (median)

6

Kolehmainen [59]

2020

Finland

Single institution-based

Obstetrics and Gynaecology, Helsinki University Hospital

Stages I-IV

2007–2012

515

Self-reported

97

HR

Medical records and death certificates

6.75 years (median)

4

Lam[38]

2018

U.S

Population-based

SEER database

Stages I-IV

2000–2011

22,743 a b

Medicare claims

NR

HR

SEER database

NR

8

Lees [53]

2021

U.S

Population-based

Wisconsin Cancer Registry

Stages I-IV

2006–2016

745

Structured interview

46

HR

National death index

19.9 years (median)

8

Lindemann[17]

2015

Norway

Population-based

Health surveys of North Trondelag (HUNT)

Stages I-IV

NR

337

Self-reported

56

HR

Cancer registry

6.7 years (median)

5

Nagle[16]

2018

Australia

Population-based

Australian National EC Study

Stages I-IV

2005–2007

1359

Self-reported

123

HR

Medical records and NDI

7.1 years (median)

6

Olson[21]

2012

U.S

Population-based

SEER-Medicare database

Stages I-IV

2000- 2005

958 c

Medicare claims

NR

HR

SEER registries

3.5 years (median)

6

Ribeiro [44]

2021

Brazil

Single institution-based

Department of

Obstetrics and Gynaecology, University of Campinas, Sao Paulo

Non-endometrioid EC stages I-IV

2002–2017

127

Medical records

NR

HR

Medical records

4.5 years (mean)

5

Ruterbusch[19]

2014

U.S

Single institution-based

Henry Ford Health System (HFHS) tumor registry

Stages I-IV

1990–2005

627

HFHS, medical records and the MDCSS

109

HR

HFHS, medical records and the MDCSS

NR

6

Simon [54]

2021

U.S

Population-based

Women’s Health Initiative (WHI)

Stages I-III

1993–1998

NR

Self-report and medication use

NR

HR

Medical records, death certificates,

relative’s report and NDI

10 years (median)

6

Sung[20]

2000

U.S. and China

Multi-institution-based

Women & Infants’ Hospital of RI, Cornell University Medical Centre, Shanghai Medical University, and Women’s and Children’s Hospital, University of Southern California

Stages I-IV

1976 to 1998

125

Medical records

112

RR

Medical records and pathology reports

5.4 years (mean)

7

VanArsdale[15]

2019

U.S

Single institution-based

Montefiore Medical Centre

Stages I-IV

1999–2016

1,732

Medical records

393

HR

Social security death index

3.4 years (median)

7

Zanders[58]

2013

Netherlands

Population-based

Eindhoven cancer registry

Endometrioid EC stages I-III

2000- 2008

388

Medical records

NR

HR

Municipal personal records

NR

8

  1. aIncluded all uterine cancer patients
  2. bOnly white patients included due to cohort overlap with Olson et al.[21]
  3. cOnly black patients included due to cohort overlap with Lam et al.[38]
  4. EC Endometrial cancer, NOS Newcastle Ottawa Scale, NDI National Death Index, SEER Surveillance, Epidemiology and End results program, MDCSS Metropolitan Detroit Cancer Surveillance System, NR Not reported, U.S. United States, RI Rhode Island, HR Hazard Ratio, RR Relative Risk